ID: ALA5270148

Max Phase: Preclinical

Molecular Formula: C22H22O4

Molecular Weight: 350.41

Associated Items:

Representations

Canonical SMILES:  CC(C)=CC/C(C)=C/COc1cc(O)c2c(=O)c3ccccc3oc2c1

Standard InChI:  InChI=1S/C22H22O4/c1-14(2)8-9-15(3)10-11-25-16-12-18(23)21-20(13-16)26-19-7-5-4-6-17(19)22(21)24/h4-8,10,12-13,23H,9,11H2,1-3H3/b15-10+

Standard InChI Key:  UAXFCSJOJOVFBQ-XNTDXEJSSA-N

Associated Targets(Human)

Alpha glucosidase 860 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 350.41Molecular Weight (Monoisotopic): 350.1518AlogP: 5.33#Rotatable Bonds: 5
Polar Surface Area: 59.67Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 8.33CX Basic pKa: CX LogP: 5.72CX LogD: 5.68
Aromatic Rings: 3Heavy Atoms: 26QED Weighted: 0.50Np Likeness Score: 1.50

References

1. Santos CMM, Freitas M, Fernandes E..  (2018)  A comprehensive review on xanthone derivatives as α-glucosidase inhibitors.,  157  [PMID:30282319] [10.1016/j.ejmech.2018.07.073]

Source